Literature DB >> 10405078

Antecedents of the risk of recovery from DSM-III-R social phobia.

D J DeWit1, A Ogborne, D R Offord, K MacDonald.   

Abstract

BACKGROUND: This study reports antecedents of recovery from DSM-III-R social phobia.
METHODS: Retrospective data were obtained from 1116 individuals age 15 to 64 participating in a large population health survey in the province of Ontario, Canada
RESULTS: Approximately 50% of the sample recovered from their illness. Survival analysis revealed a median length of illness of 25 years with peak periods of risk of recovery occurring between 30 and 45 years duration. Using discrete time multivariate hazard regression analysis, statistically significant predictors of recovery from social phobia included: childhood social contextual factors (one or no childhood siblings, a small town childhood place of residence), characteristics of the disorder (onset past the age of 7, less than three disorder symptoms), an absence of co-morbid health-related conditions and psychiatric disorders (chronic health problems and major depression), and the occurrence of co-morbid chronic health problems and major depression prior to the onset of the disorder.
CONCLUSIONS: Our data indicate that social phobia in the general population is a chronic and unremittent disorder. Determinants of recovery are rooted in distal childhood circumstances, disorder attributes, and the physical and mental health status of individuals over the life course.

Entities:  

Mesh:

Year:  1999        PMID: 10405078     DOI: 10.1017/s0033291799008399

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  18 in total

1.  Neurotic manifestations in adolescents with thalassemia major.

Authors:  J D Moorjani; Chithira Issac
Journal:  Indian J Pediatr       Date:  2006-07       Impact factor: 1.967

2.  Age Moderates Link Between Training Effects and Treatment Response to Attention Bias Modification Treatment for Social Anxiety Disorder.

Authors:  Rany Abend; Reut Naim; Lee Pergamin-Hight; Nathan A Fox; Daniel S Pine; Yair Bar-Haim
Journal:  J Abnorm Child Psychol       Date:  2019-05

3.  Attention bias modification augments cognitive-behavioral group therapy for social anxiety disorder: a randomized controlled trial.

Authors:  Amit Lazarov; Sofi Marom; Naomi Yahalom; Daniel S Pine; Haggai Hermesh; Yair Bar-Haim
Journal:  Psychol Med       Date:  2017-12-20       Impact factor: 7.723

4.  Characteristics and predictors of social phobia course in a longitudinal study of primary-care patients.

Authors:  Courtney Beard; Ethan Moitra; Risa B Weisberg; Martin B Keller
Journal:  Depress Anxiety       Date:  2010-09       Impact factor: 6.505

5.  Health-related Quality of Life across the anxiety disorders: findings from a sample of primary care patients.

Authors:  Courtney Beard; Risa B Weisberg; Martin B Keller
Journal:  J Anxiety Disord       Date:  2010-04-02

6.  Development of a cognitive-behavioral intervention program to treat anxiety and social deficits in teens with high-functioning autism.

Authors:  Susan W White; Anne Marie Albano; Cynthia R Johnson; Connie Kasari; Thomas Ollendick; Ami Klin; Donald Oswald; Lawrence Scahill
Journal:  Clin Child Fam Psychol Rev       Date:  2010-03

7.  Social fears and social phobia in the USA: results from the National Comorbidity Survey Replication.

Authors:  A M Ruscio; T A Brown; W T Chiu; J Sareen; M B Stein; R C Kessler
Journal:  Psychol Med       Date:  2007-11-02       Impact factor: 7.723

8.  Attention training in individuals with generalized social phobia: A randomized controlled trial.

Authors:  Nader Amir; Courtney Beard; Charles T Taylor; Heide Klumpp; Jason Elias; Michelle Burns; Xi Chen
Journal:  J Consult Clin Psychol       Date:  2009-10

9.  The SPAIC-11 and SPAICP-11: Two brief child- and parent-rated measures of social anxiety.

Authors:  Brian E Bunnell; Deborah C Beidel; Liwen Liu; Dana L Joseph; Charmaine Higa-McMillan
Journal:  J Anxiety Disord       Date:  2015-10-14

10.  Social anxiety disorder above and below the diagnostic threshold: prevalence, comorbidity and impairment in the general population.

Authors:  Lydia Fehm; Katja Beesdo; Frank Jacobi; Agnes Fiedler
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2007-12-14       Impact factor: 4.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.